Literature DB >> 24023336

Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.

Aroldo dos Santos Almeida1, Denise Tostes Oliveira, Michele Conceição Pereira, Simone Eloiza Sita Faustino, Suely Nonogaki, André Lopes Carvalho, Luiz Paulo Kowalski.   

Abstract

BACKGROUND: This study evaluated the clinical significance of podoplanin and vascular endothelial growth factor-C (VEGF-C) expression in oral squamous cell carcinoma (OSCC). PATIENTS AND METHODS: The immunohistochemical expression of podoplanin and VEGF-C were investigated in 42 well-differentiated OSCCs. The Chi-square test was used to analyze the association of biomarker expression with the clinical characteristics, treatment, and outcome, as well as with histopathological microscopic features and histopathological malignancy index. The relationship between podoplanin, VEGF-C and prognosis was also studied. Survival rates were calculated by the Kaplan Meier method.
RESULTS: Strong podoplanin expression was associated with male gender (p=0.037) and with early clinical stage (I-II) (p=0.027). Strong podoplanin expression was more frequently found in patients with perineural infiltration. Podoplanin and VEGF-C expression were not significant prognostic factors for patients with OSCC.
CONCLUSION: These results suggest that the strong podoplanin and VEGF-C expression by malignant cells is associated with perineural invasion in patients with OSCC.

Entities:  

Keywords:  Podoplanin; VEGF-C; oral cancer; oral squamous cell carcinoma; prognosis

Mesh:

Substances:

Year:  2013        PMID: 24023336

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.

Authors:  Stefan Huttenlocher; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Christoph Thorns; Katrin Hasselbacher; Barbara Wollenberg; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2014-06-14       Impact factor: 3.621

2.  Expression of Podoplanin in Laryngeal Squamous Cell Carcinoma and Dysplasia.

Authors:  Badawia Bayoumy Ibrahim; Mostafa Mohamed Salem; Rasha Ahmed Khairy; Reema Abdul Rahman Al Gunaid
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer.

Authors:  Agnes Assao; Suely Nonogaki; José Roberto Pereira Lauris; André Lopes Carvalho; Clóvis Antônio Lopes Pinto; Fernando Augusto Soares; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  Clin Oral Investig       Date:  2016-09-14       Impact factor: 3.573

Review 4.  Podoplanin--a novel marker in oral carcinogenesis.

Authors:  Niharika Swain; Shwetha V Kumar; Samapika Routray; Jigna Pathak; Shilpa Patel
Journal:  Tumour Biol       Date:  2014-06-27

5.  Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?

Authors:  Y F Costa; K C Tjioe; S Nonogaki; F A Soares; J R Pereira Lauris; D Tostes Oliveira
Journal:  Eur J Histochem       Date:  2015-02-24       Impact factor: 3.188

6.  Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.

Authors:  Francisco Bárbara Abreu Barros; Agnes Assao; Natália Galvão Garcia; Suely Nonogaki; André Lopes Carvalho; Fernando Augusto Soares; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  BMC Cancer       Date:  2018-01-08       Impact factor: 4.430

7.  Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.

Authors:  Silas Antonio Juvencio de Freitas Filho; Cláudia Malheiros Coutinho-Camillo; Katia Klug Oliveira; Bárbara Beltrame Bettim; Clóvis Antônio Lopes Pinto; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  J Oncol       Date:  2021-02-13       Impact factor: 4.375

8.  Study of Podoplanin Expression in Head and Neck Squamous Cell Carcinoma.

Authors:  Anjali Mary Jibi; Vijaya Basavaraj
Journal:  Iran J Pathol       Date:  2021-08-12

9.  The relationship between ezrin and podoplanin expressions in keratocystic odontogenic tumors.

Authors:  Denise Tostes Oliveira; Laís Priscila de Santis; Agnes Assao; Kellen Cristine Tjioe; Suely Nonogaki; José Roberto Pereira Lauris; Fernando Augusto Soares
Journal:  BMC Oral Health       Date:  2014-12-05       Impact factor: 2.757

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.